GYRE | Gyre Therapeutics, Inc. Annual & Quarterly Balance

Annual Balance Sheets

(In USD)

Breakdown	2023	2022	2021	2020	2019	2018
Total Assets	116.53 Million	28.44 Million	55.66 Million	94.84 Million	98.55 Million	124.92 Million
Total Current Assets	57.22 Million	28.2 Million	51.47 Million	89.51 Million	96.06 Million	123.99 Million
Cash And Short Term Investments	33.5 Million	21.66 Million	46.85 Million	79.35 Million	76.86 Million	120.12 Million
Cash and Cash Equivalents	33.5 Million	21.66 Million	44.34 Million	30.36 Million	15.36 Million	31.21 Million
Short Term Investments	-	10.59 Million	2.5 Million	48.99 Million	61.49 Million	88.91 Million
Net Receivables	16.83 Million	5 Million	1.81 Million	3.31 Million	15 Million	-
Inventory	4.28 Million	6.12 Million	5.71 Million	1000.00	-	-
Other Current Assets	1.04 Million	1.54 Million	2.8 Million	6.84 Million	4.2 Million	3.86 Million
Total Non-Current Assets	59.31 Million	238 Thousand	4.18 Million	5.33 Million	2.48 Million	929 Thousand
Net PPE	25.27 Million	70 Thousand	3.71 Million	2.26 Million	2.23 Million	386 Thousand
Good Will And Intangible Assets	205 Thousand	297 Thousand	20.76 Million	-	-	-
Good Will	-	-	-	-	-	-
Intangible Assets	205 Thousand	297 Thousand	20.76 Million	-	-	-
Long-Term Investments	23.43 Million	7.39 Million	-21.16 Million	2.54 Million	-	-
Tax Assets	4.69 Million	4.08 Million	397.23 Thousand	-	-	-
Other Non Current Assets	5.71 Million	-11.6 Million	472 Thousand	528 Thousand	257 Thousand	543 Thousand
Other Assets	-	-	-	-	-	-
Total Liabilities	102.59 Million	50.13 Million	14.57 Million	18.77 Million	30.21 Million	4.97 Million
Total Current Liabilities	20.04 Million	16.82 Million	14.16 Million	17.79 Million	28.89 Million	4.8 Million
Account Payables	355 Thousand	194 Thousand	6.41 Million	5.93 Million	4.27 Million	1.24 Million
Tax Payables	5.05 Million	2.1 Million	2.4 Million	-	-	-
Short Term Debt	210 Thousand	38 Thousand	1.97 Million	663 Thousand	483 Thousand	-
Deferred Revenue	79 Thousand	167 Thousand	230 Thousand	1.98 Million	15 Million	-
Other Current Liabilities	19.4 Million	16.42 Million	5.53 Million	9.22 Million	9.13 Million	3.55 Million
Total Non Current Liabilities	82.54 Million	33.3 Million	408 Thousand	981 Thousand	1.31 Million	174 Thousand
Long-Term Debt	199 Thousand	121 Thousand	408 Thousand	981 Thousand	1.31 Million	-
Deferred Revenue Non Current	213 Thousand	118 Thousand	891.57 Thousand	-	-	-
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	49 Thousand	33.3 Million	-891.57 Thousand	-	-	174 Thousand
Other Liabilities	-	-	-	-	-	-
Total Equity	13.94 Million	8 Million	41.08 Million	76.06 Million	68.33 Million	119.94 Million
Stock Holders Equity	-15.82 Million	-21.68 Million	41.08 Million	76.06 Million	68.33 Million	119.94 Million
Common Stock	77 Thousand	37 Thousand	31 Thousand	22 Thousand	12 Thousand	12 Thousand
Retained Earnings	-85.53 Million	-410.93 Million	-402.69 Million	-314.76 Million	-258.52 Million	-203.34 Million
Accumulated other comprehensive income	1.45 Million	2.26 Million	40.22 Million	5000.00	34 Thousand	-4000.00
Common Stock Equity	-15.82 Million	-21.68 Million	41.08 Million	76.06 Million	68.33 Million	119.94 Million
Capital Lease Obligation	409 Thousand	38 Thousand	2.38 Million	1.64 Million	1.8 Million	-
Total Investments	23.43 Million	7.39 Million	2.5 Million	51.53 Million	61.49 Million	88.91 Million
Total Debt	409 Thousand	38 Thousand	2.38 Million	1.64 Million	1.8 Million	-
Net Debt	-33.1 Million	-21.62 Million	-41.96 Million	-28.71 Million	-13.56 Million	-31.21 Million

Breakdown	2024 Q2	2024 Q1	2023 Q4	2023 FY	2023 Q3	2023 Q2
Total Assets	120.92 Million	122.01 Million	116.53 Million	116.53 Million	9.96 Million	12.39 Million
Total Current Assets	53.51 Million	62.72 Million	57.22 Million	57.22 Million	5.13 Million	7.62 Million
Cash And Short Term Investments	25.1 Million	37.35 Million	33.5 Million	33.5 Million	2.22 Million	6.92 Million
Cash and Cash Equivalents	16.09 Million	29.78 Million	33.5 Million	33.5 Million	2.22 Million	6.92 Million
Short Term Investments	9 Million	7.56 Million	-	-	-	258.41 Thousand
Net Receivables	19.9 Million	16.74 Million	15.16 Million	16.83 Million	1.2 Million	300 Thousand
Inventory	5.63 Million	4.93 Million	4.28 Million	4.28 Million	1.16 Million	5.26 Million
Other Current Assets	2.87 Million	1.89 Million	4.26 Million	1.04 Million	535 Thousand	697 Thousand
Total Non-Current Assets	67.41 Million	59.28 Million	59.31 Million	59.31 Million	4.83 Million	4.77 Million
Net PPE	27.23 Million	23.92 Million	23.77 Million	25.27 Million	23.77 Million	21.89 Million
Good Will And Intangible Assets	1.65 Million	1.67 Million	1.69 Million	205 Thousand	1.69 Million	25.03 Million
Good Will	-	-	-	-	-	-
Intangible Assets	1.65 Million	1.67 Million	1.69 Million	205 Thousand	1.69 Million	25.03 Million
Long-Term Investments	33.63 Million	23.1 Million	23.43 Million	23.43 Million	4.66 Million	4.6 Million
Tax Assets	5.07 Million	5 Million	-	4.69 Million	-30.13 Million	-51.53 Million
Other Non Current Assets	-186 Thousand	5.58 Million	10.41 Million	5.71 Million	4.83 Million	4.77 Million
Other Assets	-	-	-	-	-	-
Total Liabilities	27.58 Million	33.23 Million	38.06 Million	102.59 Million	6.44 Million	40.7 Million
Total Current Liabilities	15.57 Million	19.48 Million	20.04 Million	20.04 Million	1.78 Million	2.79 Million
Account Payables	271 Thousand	330 Thousand	355 Thousand	355 Thousand	158 Thousand	5000.00
Tax Payables	2.26 Million	6.47 Million	-	5.05 Million	-	1.5 Million
Short Term Debt	659 Thousand	100 Thousand	-	210 Thousand	-	-
Deferred Revenue	97 Thousand	75 Thousand	-	79 Thousand	-	-
Other Current Liabilities	14.54 Million	18.98 Million	19.69 Million	19.4 Million	1.62 Million	2.78 Million
Total Non Current Liabilities	12 Million	13.75 Million	18.01 Million	82.54 Million	4.66 Million	37.91 Million
Long-Term Debt	1.29 Million	175 Thousand	199 Thousand	199 Thousand	199 Thousand	2618.63
Deferred Revenue Non Current	192 Thousand	203 Thousand	-	213 Thousand	-	-
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	10.52 Million	48 Thousand	17.81 Million	49 Thousand	4.46 Million	37.91 Million
Other Liabilities	1.00	-	-	-	-	-
Total Equity	93.34 Million	88.77 Million	78.47 Million	13.94 Million	33.29 Million	-28.31 Million
Stock Holders Equity	60.35 Million	56.64 Million	48.69 Million	-15.82 Million	3.51 Million	-28.31 Million
Common Stock	85 Thousand	85 Thousand	77 Thousand	77 Thousand	37 Thousand	37 Thousand
Retained Earnings	-74.47 Million	-78 Million	-82.44 Million	-85.53 Million	-414.72 Million	-413.14 Million
Accumulated other comprehensive income	1.08 Million	1.36 Million	-1.64 Million	1.45 Million	-33.3 Million	-33.3 Million
Common Stock Equity	60.35 Million	56.64 Million	48.69 Million	-15.82 Million	3.51 Million	-28.31 Million
Capital Lease Obligation	1.29 Million	275 Thousand	409 Thousand	409 Thousand	409 Thousand	474.11 Thousand
Total Investments	42.64 Million	30.67 Million	23.43 Million	23.43 Million	4.66 Million	4.6 Million
Total Debt	1.95 Million	275 Thousand	199 Thousand	409 Thousand	199 Thousand	2618.63
Net Debt	-14.14 Million	-29.51 Million	-33.31 Million	-33.1 Million	-2.02 Million	-6.92 Million

Balance Sheet Charts

Hempfusion Wellness Inc.

CBDHF

Full Analysis

Annual Balance Sheets
Royal Group Co.,Ltd.

002329

Full Analysis

Annual Balance Sheets
Innate Pharma S.A.

IPHYF

Full Analysis

Annual Balance Sheets
B&M European Value Retail S.A.

BMRPF

Full Analysis

Annual Balance Sheets
PT Mayora Indah Tbk

MYOR

Full Analysis

Annual Balance Sheets
VIQ Solutions Inc.

VQS

Full Analysis

Annual Balance Sheets

Global Stocks Search

Gyre Therapeutics, Inc. (GYRE)

Annual Balance Sheets

Balance Sheet Charts

Hempfusion Wellness Inc.

Royal Group Co.,Ltd.

Innate Pharma S.A.

B&M European Value Retail S.A.

PT Mayora Indah Tbk

VIQ Solutions Inc.